Healthcare provider profile · identity verified

Samuel George Hall, MD

Family Practice · HANOVER, PA · NPI 1669821476

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	263	39
Gabapentin	Gabapentin	182	25
Furosemide	Furosemide	176	27
Levothyroxine Sodium	Levothyroxine Sodium	175	29
Metformin Hcl	Metformin Hcl	170	16
Metoprolol Succinate	Metoprolol Succinate	169	22
Jardiance	Empagliflozin	159	18
Lisinopril	Lisinopril	142	23
Sertraline Hcl	Sertraline Hcl	114	11
Omeprazole	Omeprazole	101	18
Eliquis	Apixaban	91	11
Metformin Hcl Er	Metformin Hcl	90	12
Famotidine	Famotidine	79	15
Quetiapine Fumarate	Quetiapine Fumarate	78	suppressed
Duloxetine Hcl	Duloxetine Hcl	71	suppressed
Amlodipine Besylate	Amlodipine Besylate	66	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	59	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	57	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	53	13
Clopidogrel	Clopidogrel Bisulfate	50	suppressed
Carvedilol	Carvedilol	49	suppressed
Finasteride	Finasteride	49	suppressed
Simvastatin	Simvastatin	49	suppressed
Lorazepam	Lorazepam	48	15
Glipizide Er	Glipizide	47	suppressed
Lamotrigine	Lamotrigine	45	suppressed
Bupropion Xl	Bupropion Hcl	44	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	44	suppressed
Prednisone	Prednisone	44	21
Diclofenac Sodium	Diclofenac Sodium	43	suppressed
Divalproex Sodium	Divalproex Sodium	43	suppressed
Olanzapine	Olanzapine	43	suppressed
Pregabalin	Pregabalin	43	suppressed
Trazodone Hcl	Trazodone Hcl	43	11
Potassium Chloride	Potassium Chloride	41	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	41	suppressed
Tramadol Hcl	Tramadol Hcl	41	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	40	suppressed
Ozempic	Semaglutide	39	suppressed
Warfarin Sodium	Warfarin Sodium	38	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	35	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	34	25
Loperamide	Loperamide Hcl	33	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	33	suppressed
Aripiprazole	Aripiprazole	31	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	29	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Trulicity	Dulaglutide	29	suppressed
Losartan Potassium	Losartan Potassium	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Ibuprofen	Ibuprofen	26	suppressed
Levetiracetam	Levetiracetam	26	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	25	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Mounjaro	Tirzepatide	24	suppressed
Oxycodone Hcl	Oxycodone Hcl	24	suppressed
Fluticasone Propionate	Fluticasone Propionate	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Primidone	Primidone	23	suppressed
Ramipril	Ramipril	23	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	23	suppressed
Valsartan	Valsartan	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Azithromycin	Azithromycin	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Incruse Ellipta	Umeclidinium Bromide	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Torsemide	Torsemide	18	suppressed
Meloxicam	Meloxicam	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Cephalexin	Cephalexin	16	13
Alendronate Sodium	Alendronate Sodium	15	suppressed
Allopurinol	Allopurinol	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Trintellix	Vortioxetine Hydrobromide	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Doxepin Hcl	Doxepin Hcl	13	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Rexulti	Brexpiprazole	13	suppressed
Zenpep	Lipase/Protease/Amylase	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Gemtesa	Vibegron	12	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Nystatin	Nystatin	12	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Topiramate	Topiramate	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Clonazepam	Clonazepam	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Glipizide	Glipizide	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Lidocaine Hcl	Lidocaine Hcl	11	suppressed
Risperidone	Risperidone	11	suppressed
Santyl	Collagenase Clostridium Hist.	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error